Friday, October 24, 2014 1:27:52 AM
The 123 million shares of stock currently (.0006) valued at $73,800.00 are given in exchange for the low interest rate 1%,
In my opinion they're basically paying the majority of the interest with shares vs. a higher interested rate. the lower rate will leave more cash ( once they start making cash) for operational expenses, production, distribution, advertising etc...
If this assumption is correct, I believe its a win / win.
Company get cash with little cash interest to pay, financier makes an additional $12,300 for every .0001 of a move in the stock price vs a set rate.
If stock actually reaches .01 they would make $1.23 million on a $1.5 million dollar loan or 82% of original loan amount.
Or company continues to miss target dates and delay production and stock falls and financier gets stuck with worthless stock and out his $1.5 million.
If Mr. Franklin is the financier he would have known about the R/S before agreeing to terms as he is listed on the SEC filing. Which I believe, is a good thing regarding the reverse split, if there is a good thing about a reverse split. He still believes enough to hand out $1.5 mil????
time will tell, I'm along for the ride as well. good luck to all!
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM